NfL makes regulatory debut as neurodegenerative disease biomarker
Asher Mullard
Topics & Concepts
Amyotrophic lateral sclerosisBiomarkerMedicineDiseaseNeuroscienceMultiple sclerosisDrugPharmacologyPathologyBiologyPsychiatryBiochemistryBiomedical Ethics and RegulationAmyotrophic Lateral Sclerosis Research